S&P 500 6,976.44 ▲ 37.41 (+0.54%)
DOW 49,407.66 ▲ 515.19 (+1.05%)
NASDAQ 23,592.11 ▲ 130.29 (+0.56%)
US Markets Closed

AGTX

Agentix Corp.

Price Chart
Latest Quote

$0.04

Current Price
Previous Close $0.05
Open $0.04
Day High $0.04
Day Low $0.04
Volume 20,000
Fetched: 2026-02-03T06:00:54
Stock Information
Shares Outstanding 40.07M
Total Debt $343K
Cash Equivalents $6K
Net Income $-656K
Sector Healthcare
Industry Biotechnology
Market Cap $1.80M
EPS (TTM) $-0.01
Exchange PNK
🌐 Visit Website
📊 Custom Metrics & Score
Score: 11/42
Debt to Equity -0.08
Debt to Earnings -0.43
Current Ratio 0.03
Quick Ratio 0.00
Avg Revenue Growth -25.00%
Return on Equity 18.27%
Avg FCF Growth -17.57%
FCF Yield -6.94%
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
Date Close Volume
2026-02-02 $0.05 0
2026-01-30 $0.05 0
2026-01-29 $0.05 20,000
2026-01-28 $0.05 2,100
2026-01-27 $0.05 2,000
2026-01-26 $0.05 7,500
2026-01-23 $0.05 15,025
2026-01-22 $0.05 60,000
2026-01-21 $0.05 0
2026-01-20 $0.05 0
2026-01-16 $0.05 0
2026-01-15 $0.05 0
2026-01-14 $0.05 0
2026-01-13 $0.05 2,400
2026-01-12 $0.04 0
2026-01-09 $0.04 0
2026-01-08 $0.04 402
2026-01-07 $0.04 0
2026-01-06 $0.04 0
2026-01-05 $0.04 0
About Agentix Corp.

Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States. It develops AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases. The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix Corp. in June 2019. Agentix Corp. was founded in 2020 and is based in Dana Point, California.

📰 Latest News
No news articles available at the moment. Check back later for updates on AGTX.
Income Statement (Annual)
Revenue
Metric 2025-03-31 2024-03-31 2023-03-31 2021-08-31
Total Revenue $0 $0 $0 $1,240
Operating Revenue $0 $0 $0 $1,240
Reconciled Cost Of Revenue - $0 $0 $561
Cost Of Revenue - $0 $0 $561
Expenses
Metric 2025-03-31 2024-03-31 2023-03-31 2021-08-31
Interest Expense $42,669 $21,034 $1,643 -
Total Expenses $513,251 $744,810 $1,371,756 $1,341,592
Other Income Expense $-11,128 $180,442 $-406 -
Net Non Operating Interest Income Expense $-42,669 $-20,786 $-1,643 $5
Interest Expense Non Operating $42,669 $21,034 $1,643 -
Operating Expense $513,251 $744,810 $1,371,756 $1,341,031
General And Administrative Expense $332,264 $569,542 $660,250 $975,899
Other Non Operating Income Expenses - $198,371 - -
Income & Earnings
Metric 2025-03-31 2024-03-31 2023-03-31 2021-08-31
Net Income From Continuing Operation Net Minority Interest $-567,048 $-585,154 $-1,373,805 $-1,340,347
Net Interest Income $-42,669 $-20,786 $-1,643 $5
Interest Income $0 $248 $0 $5
Normalized Income $-555,920 $-567,225 $-1,373,399 $-1,340,347
Net Income From Continuing And Discontinued Operation $-567,048 $-585,154 $-1,373,805 $-1,340,347
Total Operating Income As Reported $-513,251 $-744,810 $-1,371,756 $-1,340,352
Net Income Common Stockholders $-567,048 $-585,154 $-1,373,805 $-1,340,347
Net Income $-567,048 $-585,154 $-1,373,805 $-1,340,347
Net Income Including Noncontrolling Interests $-567,048 $-585,154 $-1,373,805 $-1,340,347
Net Income Continuous Operations $-567,048 $-585,154 $-1,373,805 $-1,340,347
Pretax Income $-567,048 $-585,154 $-1,373,805 $-1,340,347
Interest Income Non Operating $0 $248 $0 $5
Operating Income $-513,251 $-744,810 $-1,371,756 $-1,340,352
Gross Profit - $0 $0 $679
Per Share Metrics
Metric 2025-03-31 2024-03-31 2023-03-31 2021-08-31
Diluted EPS $-0.01 $-0.01 $-0.04 $-0.04
Basic EPS $-0.01 $-0.01 $-0.04 $-0.04
Other
Metric 2025-03-31 2024-03-31 2023-03-31 2021-08-31
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-513,251 $-546,191 $-1,371,756 $-1,340,352
Total Unusual Items $-11,128 $-17,929 $-406 -
Total Unusual Items Excluding Goodwill $-11,128 $-17,929 $-406 -
EBITDA (Bullshit earnings) $-524,379 $-564,120 $-1,372,162 $-1,340,352
EBIT $-524,379 $-564,120 $-1,372,162 $-1,340,352
Diluted Average Shares $40,066,951 $40,066,951 $39,232,019 $34,734,990
Basic Average Shares $40,066,951 $40,066,951 $39,232,019 $34,734,990
Diluted NI Availto Com Stockholders $-567,048 $-585,154 $-1,373,805 $-1,340,347
Tax Provision $0 $0 $0 $0
Gain On Sale Of Security $-11,128 $-17,929 $-406 -
Research And Development $180,987 $175,268 $711,506 $365,132
Selling General And Administration $332,264 $569,542 $660,250 $975,899
Other Gand A $332,264 $569,542 $660,250 $975,899
Fetched: 2026-02-02
Balance Sheet (Annual)
Assets
Metric 2025-03-31 2024-03-31 2023-03-31 2021-08-31
Net Tangible Assets $-3,104,249 $-2,560,222 $-2,249,163 $-555,735
Total Assets $100,274 $106,372 $261,392 $51,207
Total Non Current Assets $0 $0 $0 $0
Current Assets $100,274 $106,372 $261,392 $51,207
Prepaid Assets $95,797 $99,837 - $0
Cash Cash Equivalents And Short Term Investments $4,477 $6,535 $12,369 $1,768
Cash And Cash Equivalents $4,477 $6,535 $12,369 $1,768
Cash Financial $4,477 $6,535 $12,369 $1,768
Other Current Assets - - $249,023 -
Inventory - - - $49,439
Debt
Metric 2025-03-31 2024-03-31 2023-03-31 2021-08-31
Net Debt $238,523 $136,465 $37,631 -
Total Debt $243,000 $143,000 $50,000 -
Current Debt And Capital Lease Obligation $243,000 $143,000 $50,000 -
Current Debt $243,000 $143,000 $50,000 -
Liabilities
Metric 2025-03-31 2024-03-31 2023-03-31 2021-08-31
Total Liabilities Net Minority Interest $3,204,523 $2,666,594 $2,510,555 $606,942
Total Non Current Liabilities Net Minority Interest $0 $0 $0 $0
Current Liabilities $3,204,523 $2,666,594 $2,510,555 $606,942
Current Notes Payable $243,000 $143,000 $50,000 -
Payables And Accrued Expenses $2,961,523 $2,523,594 $2,460,555 $606,942
Payables $2,901,326 $2,499,779 $2,451,445 $606,842
Accounts Payable $2,901,326 $2,499,779 $2,451,445 $606,842
Equity
Metric 2025-03-31 2024-03-31 2023-03-31 2021-08-31
Common Stock Equity $-3,104,249 $-2,560,222 $-2,249,163 $-555,735
Total Equity Gross Minority Interest $-3,104,249 $-2,560,222 $-2,249,163 $-555,735
Stockholders Equity $-3,104,249 $-2,560,222 $-2,249,163 $-555,735
Other Equity Interest $53,535 $53,535 $53,535 $180,000
Gains Losses Not Affecting Retained Earnings $35,381 $12,360 $765 -
Other Equity Adjustments $35,381 $12,360 $765 -
Retained Earnings $-6,521,528 $-5,954,480 $-5,369,326 $-1,704,258
Other
Metric 2025-03-31 2024-03-31 2023-03-31 2021-08-31
Ordinary Shares Number $40,066,951 $40,066,951 $40,066,951 $34,874,605
Share Issued $40,066,951 $40,066,951 $40,066,951 $34,874,605
Tangible Book Value $-3,104,249 $-2,560,222 $-2,249,163 $-555,735
Invested Capital $-2,861,249 $-2,417,222 $-2,199,163 $-555,735
Working Capital $-3,104,249 $-2,560,222 $-2,249,163 $-555,735
Total Capitalization $-3,104,249 $-2,560,222 $-2,249,163 $-555,735
Additional Paid In Capital $3,288,296 $3,288,296 $3,025,796 $933,648
Capital Stock $40,067 $40,067 $40,067 $34,875
Common Stock $40,067 $40,067 $40,067 $34,875
Current Accrued Expenses $60,197 $23,815 $9,110 $100
Dueto Related Parties Current - $1,538,118 $1,394,230 $485,603
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Free Cash Flow
Metric 2025-03-31 2024-03-31 2023-03-31 2021-08-31
Free Cash Flow $-125,078 $-110,429 $-88,541 $-420,982
Operating Activities
Metric 2025-03-31 2024-03-31 2023-03-31 2021-08-31
Operating Cash Flow $-125,078 $-110,429 $-88,541 $-420,982
Cash Flow From Continuing Operating Activities $-125,078 $-110,429 $-88,541 $-420,982
Investing Activities
Metric 2025-03-31 2024-03-31 2023-03-31 2021-08-31
Investing Cash Flow $0 $0 $0 $0
Cash Flow From Continuing Investing Activities - - - $0
Financing Activities
Metric 2025-03-31 2024-03-31 2023-03-31 2021-08-31
Financing Cash Flow $100,000 $93,000 $100,000 $180,000
Cash Flow From Continuing Financing Activities $100,000 $93,000 $100,000 $180,000
Issuance Of Capital Stock - $0 $50,000 $180,000
Net Common Stock Issuance - $0 $50,000 $180,000
Common Stock Issuance - $0 $50,000 $180,000
Other
Metric 2025-03-31 2024-03-31 2023-03-31 2021-08-31
Repayment Of Debt $0 $-70,000 $0 -
Issuance Of Debt $100,000 $163,000 $50,000 -
Interest Paid Supplemental Data $0 $3,223 $0 $0
Income Tax Paid Supplemental Data $0 $0 $0 $0
End Cash Position $4,477 $6,535 $12,369 $1,768
Beginning Cash Position $6,535 $12,369 $145 $242,750
Effect Of Exchange Rate Changes $23,020 $11,595 $765 -
Changes In Cash $-25,078 $-17,429 $11,459 $-240,982
Net Issuance Payments Of Debt $100,000 $93,000 $50,000 -
Net Long Term Debt Issuance $100,000 $93,000 $50,000 -
Long Term Debt Payments $0 $-70,000 $0 -
Long Term Debt Issuance $100,000 $163,000 $50,000 -
Change In Working Capital $441,970 $180,649 $1,146,435 $538,215
Change In Payables And Accrued Expense $437,929 $63,040 $1,367,578 $537,654
Change In Prepaid Assets $4,041 $117,609 $-221,143 $50,000
Net Income From Continuing Operations $-567,048 $-585,154 $-1,373,805 $-1,340,347
Other Non Cash Items - $294,076 $138,829 $381,150
Amortization Of Securities - - $19,954 -
Net Business Purchase And Sale - - - $0
Sale Of Business - - - $0
Change In Inventory - - - $-49,439
Provisionand Write Offof Assets - - - $0
Asset Impairment Charge - - - $0
Fetched: 2026-02-02